You are here: Industry Insights > GenScript

News List

GenScript Receives EUA for Use of cPass SARS-CoV-2 Neutralization Antibody Test americanpharmaceuticalreview
February 24, 2021
GenScript has received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in convalescent plasma ...
GenScript and InnoBation Enter into the Agreement for CAR-T therapy prnasia
December 15, 2020
A global leading biotech company GenScript Biotech Corporation announces that it has reached the agreement for cell line development and engineering, manufacture service of GMP Plasmids and Lentivirus with InnoBation Co., Ltd. a company that ...
GenScript Receives EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit americanpharmaceuticalreview
November 18, 2020
GenScript USA announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit.
GenScript Expands CDMO Capabilities contractpharma
July 24, 2020
Launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum in Shanghai.
Duke, GenScript, A*STAR Enter COVID-19 Pact contractpharma
May 19, 2020
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimen.
GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids prnasia
January 16, 2020
By entering this strategic partnership agreement, GenScript and Genopis establish a revenue-sharing agreement for the promotion, selling, and production of GMP plasmids globally.
GenScript and Selecxine Enter Into Strategic Cooperation Agreement prnasia
January 05, 2020
According to the agreement, GenScript will be responsible for preclinical pharmacy research and IND filing in Selecxine's project.
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation prnasia
December 26, 2019
The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation on December 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy industry,
GenScript Partners with Harvard to Develop Ultra-safe Cells Resistant to Natural Viruses contractpharma
September 24, 2019
GenScript, a gene synthesis provider, will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project ...
GenScript Biotech Opens Biologics R&D and Production Center contractpharma
July 22, 2019
Meets all U.S., EU and Chinese GMP requirements.

Previous page 1 2 3 Next page